Drug Database
Back to search

Belgium· BE-AMP-SAM660763-00

Genvoya 90 mg - 90 mg - 120 mg - 6 mg

A emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat product containing tenofovir alafenamide fumarate, registered in Belgium by Gilead Sciences Ireland UC. The same ATC class is registered in 13 of our 19 countries.

ATC J05AR18

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedGenvoya 90 mg - 90 mg - 120 mg - 6 mgATCJ05AR18REGISTER NO.BE-AMP-SAM660763-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tenofovir alafenamide fumarateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR18 (emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose
Search emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat products by name

Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat · ATC J05AR18

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Tenofovir Alafenamide Fumarate
Manufacturer
Gilead Sciences Ireland UC
Country
Belgium (BE)
ATC code
J05AR18
ATC class
Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Germany · Tenofoviralafenamid Devatis
  • Iceland · Vemlidy
  • Liechtenstein · Vemlidy
  • Netherlands · Tenofoviralafenamide Devatis
  • Norway · Vemlidy
  • Portugal · Tenofovir Alafenamida Humanis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/eae736d1-90f0-4a25-8166-cc37cc5ebcab
GET /v1/drugs/eae736d1-90f0-4a25-8166-cc37cc5ebcab?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Genvoya 90 mg - 90 mg - 120 mg - 6 mg",
  "name_fr": "Genvoya 90 mg - 90 mg - 120 mg - 6 mg",
  "name_nl": "Genvoya 90 mg - 90 mg - 120 mg - 6 mg",
  "amp_code": "SAM660763-00",
  "strengths": [
    "90.0000",
    "6.0000",
    "90.0000",
    "90.0000",
    "120.0000",
    "6.0000",
    "6.0000",
    "120.0000",
    "90.0000",
    "35.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Tenofovir Alafenamide Fumarate",
    "Elvitegravir",
    "Tenofovir Alafenamide",
    "Cobicistat",
    "Emtricitabine",
    "Lactose",
    "Sodium Laurilsulfate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Emtricitabine, Tenofovir Alafenamide, Elvitegravir and Cobicistat",
  "authorisation_numbers": [
    "EU/1/15/1061/003",
    "EU/1/15/1061/004"
  ]
}
API referenceMCP serverPlans

See everything about emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console